|
KRAS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.579200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.752000E-01 |
| Normal-vs-Stage2 |
7.296200E-01 |
| Normal-vs-Stage3 |
7.567000E-01 |
| Normal-vs-Stage4 |
2.934800E-01 |
| Stage1-vs-Stage2 |
9.981200E-01 |
| Stage1-vs-Stage3 |
9.181200E-01 |
| Stage1-vs-Stage4 |
3.513200E-01 |
| Stage2-vs-Stage3 |
9.430400E-01 |
| Stage2-vs-Stage4 |
4.266200E-01 |
| Stage3-vs-Stage4 |
4.352400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.603200E-01 |
| Normal-vs-AfricanAmerican |
7.221600E-02 |
| Normal-vs-Asian |
1.742840E-01 |
| Caucasian-vs-AfricanAmerican |
1.634440E-01 |
| Caucasian-vs-Asian |
3.927800E-01 |
| AfricanAmerican-vs-Asian |
1.586240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.779800E-01 |
| Normal-vs-Female |
2.115000E-01 |
| Male-vs-Female |
5.477600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.124800E-01 |
| Normal-vs-Extreme_Weight |
9.125800E-01 |
| Normal-vs-Obese |
1.839590E-01 |
| Normal-vs-Extreme_Obese |
9.712200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.522800E-01 |
| Normal_Weight-vs-Obese |
2.996000E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.891400E-01 |
| Extreme_Weight-vs-Obese |
2.771400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.886000E-01 |
| Obese-vs-Extreme_Obese |
5.528600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.551600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.757900E-02 |
| Normal-vs-Age(61-80Yrs) |
8.491400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.769400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.056800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.696800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.314400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.430440E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.513800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.052800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.393860E-02 |
| Normal-VS-Type2 PRCC |
2.813500E-02 |
| Normal-VS-KIRP CIMP |
5.452800E-01 |
| Normal-VS-Unclassified PRCC |
2.728800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.27299999999708E-06 |
| Type1 PRCC-VS-KIRP CIMP |
1.821720E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.315200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.724000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.031700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.610390E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.388400E-01 |
| Normal-vs-N1 |
7.589400E-01 |
| Normal-vs-N2 |
2.112800E-01 |
| N0-vs-N1 |
2.773800E-01 |
| N0-vs-N2 |
7.942600E-01 |
| N1-vs-N2 |
3.559000E-01 |
|
|
